Pacira Pharma (PCRX) Tops Q2 EPS by 17c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus
Go back to Pacira Pharma (PCRX) Tops Q2 EPS by 17c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus| PACIRA (NASDAQ: PCRX) | Delayed: 22.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.71 | 52 Week High | $80.25 | |||
| Open | $22.71 | 52 Week Low | $30.25 | |||
| Day High | $22.71 | P/E | N/A | |||
| Day Low | $22.71 | EPS | $-2.08 | |||
| Volume | 859 | |||||

